MDL Mass Tort & Class Action Monitor
Developed to serve primarily as a litigation scouting report for plaintiff and defense counsel, insurers and legal service providers, HarrisMartin’s MDL Mass Tort & Class Action Monitor covers significant new filings and decisions in the JPML, MDL and related mass tort arenas. The quick delivery of breaking news and additional features will keep you within close range of every development occurring in the high-stakes environment of mass torts litigation — where minutes can make a difference. The MDL Mass Tort & Class Action Monitor is an online-only offering that includes frequent email updates and is available at no charge to annual and event sponsors of HarrisMartin’s CLE Conferences.
Cyber Monday Promotion Extended through 12/6! Subscribe now at half-price - promotion good on new, annual subscriptions only. Discount already removed from annual subscription rate.
SEARCH THE ARCHIVES
Zantac Defendants Support Efforts to Create MDL Docket; Agree with District of New Jersey as Destination
Defendants named in Zantac personal injury lawsuits have supported recent plaintiff efforts to create a multidistrict litigation docket for the growing number of cases, agreeing with the petitioner’s suggestion that the cases be centralized in the District of New Jersey.
A plaintiff with claims pending against Allergan for its Biocell textured breast implants has opposed the suggested location of the proposed multidistrict litigation docket, arguing instead that the Southern District of Florida is the “best venue choice, because its docket conditions are much more favorable than those of the other districts under consideration.”
C-8 MDL Court Awards Plaintiffs Summary Judgment on Application of Collateral Estoppel to Certain Issues
The federal court overseeing the multidistrict litigation docket for C-8 personal injury claims has awarded plaintiffs summary judgment on the application of collateral estoppel to certain issues, saying the move was justified given, in part, that DuPont settled the only remaining bellwether cases, therefore leaving no bellwether cases unresolved.
A Maryland federal judge has denied Smith & Nephew Inc.’s request to make appealable a ruling that claims relating to the “hybrid” Birmingham Hip Resurfacing-THA and R3-THA hip replacement systems and components are not preempted.
The 3rd Circuit U.S. Court of Appeals has remanded thousands of Fosamax cases to New Jersey federal court for a determination as to whether federal law preempts the plaintiffs’ claims.
According to a recent court filing by Smith & Nephew Inc., there are 722 total active cases pending on the Birmingham Hip Resurfacing multidistrict litigation docket in Maryland federal court.
As of Dec. 2, there were 9,903 product liability cases pending on the DePuy Pinnacle Hip Implant Products Liability Multidistrict Litigation docket pending in Dallas, according to a recent filing.
The New Jersey Supreme Court has designated cases involving allegations of injuries from several popular heartburn drugs known as proton-pump inhibitors (PPIs) as multicounty litigation, according to a recent order.
Plaintiffs alleging injuries caused by Stryker’s Tritanium Acetabular Shell hip replacement device have asked the New Jersey Supreme Court to designate the cases as multicounty litigation, arguing that their claims have “common, recurrent issues of law and fact that are associated with a single product.”
Plaintiffs with claims pending against supermarket chain Hy-Vee Inc. for an alleged data breach have asked the U.S. Judicial Panel on Multidistrict Litigation to create a coordinated docket for the actions, saying as more details surface regarding the impact and scope of the data breach, “it is possible that other cases will be filed in the future.”